Cargando...

Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation

Gardado en:
Detalles Bibliográficos
Publicado en:Kidney Int Rep
Main Authors: Ainley, Louise, Law, Steven, Heptinstall, Lauren, Rodriguez-Justo, Manuel, Thomson, Kirsty, Pepper, Ruth J.
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2020
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7783564/
https://ncbi.nlm.nih.gov/pubmed/33426402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2020.10.012
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!